A 66-Year-Old Man With Gastric Carcinoma

EP. 1: Patient Case With HER2+ Gastric Carcinoma

ByBassel El-Rayes, MD

April 6th 2021

EP. 2: Molecular Testing for Gastric Carcinoma

ByBassel El-Rayes, MD

April 6th 2021

EP. 3: Treatment Options for Gastric Carcinoma

ByBassel El-Rayes, MD

April 6th 2021

EP. 4: The DESTINY-Gastric01 Trial and Mechanisms of Resistance in Gastric Carcinoma

ByBassel El-Rayes, MD

April 6th 2021

EP. 5: Future Directions and Unmet Needs for Gastric Carcinoma

ByBassel El-Rayes, MD

April 6th 2021

EP. 6: Trastuzumab Deruxtecan for HER2+ Gastric Cancer

ByBassel El-Rayes, MD

April 6th 2021

Bassel El-Rayes, MD, an expert in oncology, discusses the DESTINY-Gastric01 trial of trastuzumab deruxtecan in HER2+ gastric cancer and comments on implications for second-line treatment and beyond.